Skip to main content

Table 3 In vitro response of P. falciparum to anti-malarial drugs in the 1998, 2001, 2004/5, and 2008/9 surveys

From: Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009

Drug

Year

Sample

EC50 (95% CI) 1

EC90 (95% CI)

EC 99 (95% CI)

Chloroquine

1998

30

36.7 (27.6 - 48.7)

129 (85.5-194)

360 (196 - 659)

 

2001

59

24.4 (19.6 - 30.2)

72.5 (51.2-103)

177 (103 - 302)

 

2004/5

34

37.7 (25.8-55.0)

293 (139-617)

1,562 (462 -5,279)

 

2008/9

81

67.8 (56.1 - 82.0)

253 (202-358)

735 (535 - 1,272)

Mefloquine

1998

35

83.3 (66.5 - 104)

201 (149-270)

412 (272-622)

 

2001

59

42.2 (35.5-50.1)

101 (78.9-129)

205 (143 - 293)

 

2004/5

25

60 (42.2 - 85.6)

250 (145-430)

796 (347 - 1,824)

Quinine

1998

31

245 (176-320)

820 (494-1,361)

2,197 (1,018-4,746)

 

2001

58

96.3

(78- 119)

277

(199-387)

658

(394-1,098)

Artemisinin2

1998

34

30.5 (20.4- 45.5)

201 (111-364)

937 (387 - 2,269)

 

2001

58

26.9 (17.2-42.2)

426 (198-914)

4041 (1213-13461)

 

2004/5

34

13.7 (8.5 - 22.0)

126 (58.6 - 272)

772 (235-2,537)

 

2008/9

46

17.4 (12.0 - 25.3)

92.0 (54.9 - 154)

358 (170 -756)

Piperaquine

2008/9

81

21.1 (16.5-27.1)

62 (91.8-136)

304 (167-554)

DHA

2008/9

81

1.7 (1.4 - 2.2)

14.1 (9-22)

78 (37-163)

  1. 1. Values are mean effective concentrations (EC) for P. falciparum isolates (number = n) calculated for 50%, 90%, 99% schizont maturation inhibition. Units: nmol/L blood medium mix and 95% confidence intervals.
  2. 2. Fresh microtest plates prepared at NIMPE were used in the artemisinin experiments. These were replenished in the field every three months in 1998 and 2001, and every 2 weeks in 2004/5 and 2008/9